Chinese Japanese Germany Korea
ChemicalBook >> CAS DataBase List >>Girentuximab

Girentuximab

Girentuximab Structure
Girentuximab structure
CAS No.
916138-87-9
Chemical Name:
Girentuximab
Synonyms
Girentuximab;cG250|||WX-G250|||G250;Girentuximab (anti-CA9);Research Grade Girentuximab(DHH37201)
CBNumber:
CB98080810
Molecular Formula:
Molecular Weight:
0
MDL Number:
MOL File:
Mol file
Last updated:2024-07-02 08:55:42
Request For Quotation

Girentuximab Properties

storage temp. Store at -20°C
form Liquid
color Colorless to light yellow
FDA UNII 539B57DFJF
NCI Drug Dictionary girentuximab

Girentuximab Preparation Products And Raw materials

Raw materials

Preparation Products

Girentuximab Suppliers

Global( 9)Suppliers
Supplier Tel Email Country ProdList Advantage
Aladdin Scientific 		+1-+1(833)-552-7181 sales@aladdinsci.com United States 57511 58
ShangHai Biochempartner Co.,Ltd 17754423994 17754423994 2853530910@QQ.com China 8011 62
Wuhan Chemstan Biotechnology Co., Ltd. 027-65317797 15926423062 422450190@qq.com China 10333 58
AntibodySystem 17762345272 18162686757 biolab-reagents@atagenix.com China 9819 58
Wuhan Jingkangen Biomedical Technology Co., Ltd 13720134139 13720134139 orders@jknbiochem.com China 5388 58
Shanghai?Medlife?Pharm-Tech?Co.,?Ltd 021-59167510 18117107507 vip@med-life.cn China 5012 58
Shanghai Aladdin Biochemical Technology Co.,Ltd. +86-18521732826 market@aladdin-e.com China 48466 58
Changsha Fuzhen Biotechnology Co.，LTD 0731-18670069 18670069958 184792226@qq.com China 3194 58
TargetMol Chemicals Inc. 15002134094 marketing@targetmol.cn China 28091 58
Supplier Advantage
Aladdin Scientific 		58
ShangHai Biochempartner Co.,Ltd 62
Wuhan Chemstan Biotechnology Co., Ltd. 58
AntibodySystem 58
Wuhan Jingkangen Biomedical Technology Co., Ltd 58
Shanghai?Medlife?Pharm-Tech?Co.,?Ltd 58
Shanghai Aladdin Biochemical Technology Co.,Ltd. 58
Changsha Fuzhen Biotechnology Co.，LTD 58
TargetMol Chemicals Inc. 58

916138-87-9(Girentuximab)Related Search:

varlilumab Eptinezumab Atezolizumab Obinutuzumab Sutimlimab
Utomilumab Glofitamab Nesvacumab Odronextamab Rituximab

1of2

Girentuximab Research Grade Girentuximab(DHH37201) Girentuximab (anti-CA9) cG250|||WX-G250|||G250 916138-87-9